Eledon Pharmaceuticals, Inc.
- ELDN
- NASDAQ
- Biotechnology
- Clinical-Stage Biotech
- Immunology/Transplant
$2.13
Today −6.17%Quote Oct 16, 2026, 08:00 PM UTC
−19.62%over the last month
Max drawdown −26.3%From 1-month high −26.3%3 months −44.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$173.1M
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Analyst target
$7.00
+228.6% from here
Floor
$2.08
2.5% below price
Where the price sits
4 analysts
Analyst range, low to high
$5.00$9.00
- Price $2.13
- Resistance $2.16
- Consensus $7.00
The price is right under resistance. Analysts' average target sits about 229% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ELDNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
33